RARE-15. Astroblastoma, MN1 altered comprises two molecularly and clinically distinct subgroups defined by the fusion partners BEND2 and CXXC5

Authors: Felix Schmitt-Hoffner, Johannes Gojo, Monika Mauermann, Katja von Hoff, Martin Sill, Damian Stichel, David Capper, Arnault Tauziede-Espariat, Pascale Varlet, Kenneth Aldape, Zied Abdullaev, Andrew M Donson, Ulrich Schüller, Matija Snuderl, Sebastian Brandner, Maria Łastowska, Joanna Trubicka, Evelina Miele, Jasper van der Lugt, Jens Bunt, Christof Kramm, Michal Zapotocky, Felix Sahm, Andrey Korshunov, Natalie Jäger, Stefan M Pfister, Marcel Kool

Published: 2022-06-03

DOI: 10.1093/neuonc/noac079.040

Source: Full article

RARE-15. Astroblastoma, <i>MN1</i> altered comprises two molecularly and clinically distinct subgroups defined by the fusion partners <i>BEND2</i> and <i>CXXC5</i>

Abstract